We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · November 16, 2021

IOP-Related Events After Anti–VEGF Therapy for Macular Edema

JAMA Ophthalmology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Ophthalmology
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol 2021 Oct 28;[EPub Ahead of Print], AA Aref, IU Scott, PC VanVeldhuisen, J King, MS Ip, BA Blodi, NL Oden

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading